A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients
Clinical trial NCT01161368 · TERMINATED
Trial details
- NCT number
- NCT01161368
- Sponsor
- Central European Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2014-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.